about
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle p...
Read More
35.90
-0.73
(-1.99%)
1.0M
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Cytokinetics Inc is on 08 Aug 2025 for the purpose of Cytokinetics Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
Cytokinetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..